WhatsApp Chat with us

Get in touch

08045479032

Working Hours

Mon - Sat 8:00 - 6:30
Trastuzumab injection Trastuzumab injection

Trastuzumab injection

12000.0 INR/Bottle

Product Details:

  • Indication HER2-positive breast cancer, metastatic gastric cancer
  • Salt Composition Trastuzumab
  • Dosage Form Injection
  • Enzyme Types Monoclonal Antibody (not an enzyme)
  • Ingredients Trastuzumab lyophilized powder, excipients
  • Application Intravenous administration
  • Ph Level 6.0
  • Click to view more
X

Trastuzumab injection Price And Quantity

  • 1 Pack
  • 12000.0 INR/Bottle

Trastuzumab injection Product Specifications

  • HER2-positive breast cancer, metastatic gastric cancer
  • White to pale yellow lyophilized powder
  • 24 months
  • Trastuzumab lyophilized powder, excipients
  • Odorless
  • Monoclonal Antibody (not an enzyme)
  • Trastuzumab
  • Store at 2C to 8C; do not freeze
  • Injection
  • 6.0
  • Not applicable; manufacturing uses mammalian cell culture
  • Intravenous administration
  • Single-use vial
  • Hypersensitivity to Trastuzumab or excipients
  • Antineoplastic agent, Monoclonal antibody
  • Reconstitute with sterile water for injection
  • Use immediately or store refrigerated up to 24 hours
  • Sterile Water for Injection (SWFI)
  • Monitor cardiac function before and during treatment
  • 440 mg/vial
  • Recombinant DNA technology in mammalian cells
  • Intravenous infusion only

Trastuzumab injection Trade Information

  • 50 Pack Per Month
  • 7 Days
  • No
  • Asia, Central America, South America, Eastern Europe, Western Europe, Middle East, Africa, Australia, North America
  • All India

Product Description

Herti 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).


Targeted Therapy for HER2-Positive Cancers

Trastuzumab injection specifically targets the HER2 protein, providing effective treatment for HER2-positive breast and metastatic gastric cancer patients. Its action mechanism helps slow cancer progression, often improving patient outcomes.


Proper Reconstitution and Administration

The lyophilized powder must be reconstituted with sterile water for injection and administered exclusively as an intravenous infusion. Once prepared, the reconstituted solution should be used immediately or refrigerated for up to 24 hours to ensure efficacy and safety.


Handling and Storage Recommendations

Store the lyophilized vial at 2C to 8C and protect it from freezing. After reconstitution, any unused solution should be discarded after 24 hours. Always use under appropriate medical supervision to ensure patient safety.

FAQ's of Trastuzumab injection:


Q: How should Trastuzumab injection be prepared and administered?

A: Trastuzumab injection is supplied as a white to pale yellow lyophilized powder. It should be reconstituted with sterile water for injection, and the resulting solution administered intravenously as an infusion by a healthcare professional.

Q: What conditions does Trastuzumab treat?

A: Trastuzumab is indicated for the treatment of HER2-positive breast cancer and metastatic gastric cancer, targeting tumors that overexpress the HER2 protein.

Q: When should Trastuzumab injection be used after reconstitution?

A: It is best to use Trastuzumab immediately after reconstitution. If this is not possible, the solution can be stored under refrigeration (2C to 8C) and must be used within 24 hours.

Q: Where should Trastuzumab vials be stored before and after preparation?

A: Unreconstituted vials should be stored in a refrigerator at 2C to 8C. After reconstitution, the solution should be kept refrigerated and used within 24 hours; do not freeze at any stage.

Q: What monitoring is required during Trastuzumab treatment?

A: Cardiac function should be assessed before starting therapy and monitored periodically throughout treatment, as Trastuzumab can affect heart function in some patients.

Q: What are the benefits of using Trastuzumab for cancer treatment?

A: Trastuzumab is a targeted therapy that offers improved outcomes for patients with HER2-positive cancers, lowering the risk of disease progression compared to non-targeted treatments.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicine' category



Back to top